Mr. Jannotta serves as a Board Member at Alcyone Lifesciences. He also serves as Senior Advisor at Thornapple River Capital. He began his career as an associate with GTCR in 1985. After spending three years with GTCR, he left to join William Blair Capital Partners, where he was a managing director for over nine years. He rejoined GTCR in 1998 and became managing principal in 2002. Mr. Jannotta holds an AB in Politics, cum laude, from Princeton University and an MBA from Harvard University. Mr. Jannotta is a director of Graceway Pharmaceuticals, GeneraMedix Pharmaceuticals and Ovation Pharmaceuticals. In addition, Mr. Jannotta was a director and played a key role in GTCR's highly successful past investments in CuraScript and LifeCare Management Services.